Actively Recruiting
Retrospective Review of Esophageal Cancer at MSKCC
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-03-09
4000
Participants Needed
1
Research Sites
528 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Residual tumor at the proximal or distal margin after esophagectomy is a known prognostic factor for poor survival outcomes in patients with esophageal cancer; however, the significance of the circumferential resection margin (CRM) remains controversial. In this study, the investigators sought to evaluate the prognostic significance of the CRM in patients with esophageal cancer undergoing resection.
CONDITIONS
Official Title
Retrospective Review of Esophageal Cancer at MSKCC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed esophageal adenocarcinoma or esophageal squamous cell carcinoma
- Undergoing esophagectomy
- Pathologic staged T3 tumors (pT3)
You will not qualify if you...
- Pathologic staged T0-2 (pT0-2) or T4 tumors (pT4)
- Histologic types other than esophageal adenocarcinoma or squamous cell carcinoma, including dysplasia or carcinoma in situ without tumor invasion
- Undergoing salvage esophagectomy
- Evidence of distant metastatic disease
- Positive proximal or distal tumor margin after surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States, 10065
Actively Recruiting
Research Team
D
Daniela Molena, MD
CONTACT
J
James Isbell, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here